Recall Record

Toronto, Canada

Luminex Molecular Diagnostics recalls

3 recalls recorded since 2018, most recently on 5 September 2024. 3 are listed as ongoing. Status and classification are as published by the FDA.

Recalls3
Ongoing (FDA)3
Terminated or completed0
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
5 September 2024
Reason
Respiratory pathogen panel may report an elevated rate (7.6% predicted probability of occurrence) of non-specific hMPV target (human Metapneumovirus) results, risk identified predominantly in clinical samples that present positivity for another target, leading to an erroneous co-infection result, can potentially result in hMPV false positives.
Distribution
U Nationwide distribution in the states of OH, CA, NC, WI, TN, TX, MI, NY, MO, FL, MA, NJ, PA, VA, AZ, IL, OK, CO, MN.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0043-2025, Z-0042-2025

Ongoing Class II Medical devices

Recall started
16 July 2019
Reason
The Assay may give a false negative result when detecting and subtyping Influenza A (H3) and detecting RSV A in patient specimens. However, the assay will continue to detect Influenza A, Influenza B, RSV B and all other targets in accordance with each of these products performance claims.
Distribution
US distribution to CA, CT, MA, and PA OUS: None
Initiated
Voluntary: Firm initiated
Recall number
Z-0161-2020

Ongoing Class II Medical devices

Recall started
22 February 2019
Reason
Reports have been received of lower MS2 MFI values when using the panel.
Distribution
Distribution from the firm's Austin, Texas, location was made to AL, AR, AZ, CA, FL, GA, IL, IN, MO, NC, ND, NJ, NY, OK, TN, TX, VA, and WI. There was military distribution but no government distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1767-2019

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.